iXensor Co., Ltd. (TPEX:6734)
7.85
+1.75 (28.69%)
Sep 11, 2026, 2:05 PM CST
iXensor Revenue
iXensor had revenue of 12.32M TWD in the half year ending June 30, 2026, with 66.32% growth. This brings the company's revenue in the last twelve months to 26.67M, up 8.46% year-over-year. In the year 2025, iXensor had annual revenue of 26.88M with 38.14% growth.
Revenue (ttm)
26.67M
Revenue Growth
+8.46%
P/S Ratio
11.39
Revenue / Employee
n/a
Employees
n/a
Market Cap
303.86M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.88M | 7.42M | 38.14% |
| Dec 31, 2024 | 19.46M | -1.43M | -6.85% |
| Dec 31, 2023 | 20.89M | -84.35M | -80.15% |
| Dec 31, 2022 | 105.24M | 80.44M | 324.44% |
| Dec 31, 2021 | 24.79M | 8.87M | 55.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cowealth Medical Holding | 2.90B |
| Diamond Biotechnology | 464.63M |
| EPS Bio Technology | 418.74M |
| Radiant Innovation | 409.16M |
| Health & Life | 400.09M |
| Taiwan Advanced Nanotech | 170.57M |
| PlexBio | 137.57M |